Yahoo Finance

HACKENSACK, N.J. (AP) — HACKENSACK, N.J. (AP) — Protalix BioTherapeutics Inc. (PLX) on Friday reported a loss of $3.6 million in its first quarter.

On a per-share basis, the Hackensack, New Jersey-based company said it had a loss of 5 cents.

The drug developer posted revenue of $10.1 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PLX at https://www.zacks.com/ap/PLX